Quercetin Sleep Randomized Trial: What the Evidence Says

Quercetin Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed

3 min read · 534 wordsReviewed June 2026
A woman peacefully sleeps on a soft pillow, capturing the essence of comfort and relaxation indoors. - Evidence evidence guide for quercetin sleep randomized trial
Photo by Andrea Piacquadio on Pexels · Pexels License

Quick Answer

Quercetin Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 2 narrative review.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Quercetin Sleep Randomized Trial: What the Evidence Says

Quick Answer

Quercetin Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 2 narrative review.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities narrative review 3 2026-05-01 10.1002/fsn3.71856
Probiotics and Phytoantioxidants Target Coronary Endothelial Dysfunction in Irregular Sleep- and Obesity-Associated Cardiometabolic Syndrome narrative review 3 2025-11-12 10.3390/life15111740

What The Sources Report

  • Polyphenols strengthen the intestinal barrier and reduce endotoxemia; cocoa bean shell extracts protected against oxysterol-induced intestinal damage and improved gut microbiota composition in preclinical models (Alia et al. ). [Akif Adnan (2026); evidence level 3]
  • While many epidemiological studies correlate polyphenol-rich diets (e.g., Mediterranean diet) with reduced NCCD risk, causality is uncertain due to confounding and measurement error. [Akif Adnan (2026); evidence level 3]
  • These effects are particularly relevant in obesity-associated coronary endothelial dysfunction, where microbial metabolites including trimethylamine N-oxide (TMAO) and lipopolysaccharides (LPS) contribute to oxidative stress and vascular inflammation. [Tseng Chi-Nan (2025); evidence level 3]
  • This review synthesizes current evidence on the mechanistic roles of probiotics and phytoantioxidants in modulating microbiota-derived metabolites and host signaling pathways. [Tseng Chi-Nan (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For quercetin sleep randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Akif Adnan (2026). Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities. DOI: 10.1002/fsn3.71856. PMCID: PMC13135109. PMID: 42079325. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13135109/
  • Tseng Chi-Nan (2025). Probiotics and Phytoantioxidants Target Coronary Endothelial Dysfunction in Irregular Sleep- and Obesity-Associated Cardiometabolic Syndrome. DOI: 10.3390/life15111740. PMCID: PMC12653415. PMID: 41302164. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12653415/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed June 7, 2026 by Migaku Evidence Review

Related content

← All GuidesSupplement Reference →